Healthcare -
Biotechnology - NASDAQ - US
$ 40.58
-1.27 %
$ 3.14 B
Market Cap
-312.15
P/E
VCYT - STOCK-BASED COMPENSATION
Stock-based Compensation VCYT - Veracyte, Inc.
33.1 M
LAST VALUE
21.31%
2 YEAR CAGR
40.95%
5 YEAR CAGR
38.82%
10 YEAR CAGR